MAPT and amyloidosis: Moreover, no other user-friendly software includes models for characterizing the intra-brain spreading of alteration effects (e.g., connectome-mediated tau and amyloid propagation as characterized by ESM and MCM) or for identifying individual therapeutic needs based on dynamical system analysis and control theory (e.g., pTIF).